
Updated guidance recommends biennial prostate-specific antigen testing for average-risk men aged 50 to 69 years and annual screening beginning at age 45 for higher-risk men.
A 75-Year-Old Man With Metastatic Castrate-Resistant Prostate Cancer
Case: A 75-Year-Old Male with Metastatic Castrate-Resistant Prostate Cancer
Initial presentation
2015
Clinical workup
Treatment and Follow-Up
2017
2018



